Coronavirus main proteinase (3CLpro) structure:: Basis for design of anti-SARS drugs

被引:1376
作者
Anand, K
Ziebuhr, J
Wadhwani, P
Mesters, JR
Hilgenfeld, R
机构
[1] Univ Lubeck, Inst Biochem, D-23538 Lubeck, Germany
[2] Inst Mol Biotechnol, D-07745 Jena, Germany
[3] Univ Wurzburg, Inst Virol & Immunol, D-97078 Wurzburg, Germany
[4] Univ Jena, Inst Mol Biol, D-07745 Jena, Germany
关键词
D O I
10.1126/science.1085658
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
A novel coronavirus has been identified as the causative agent of severe acute respiratory syndrome (SARS). The viral main proteinase (M-pro, also called 3CL(pro)), which controls the activities of the coronavirus replication complex, is an attractive target for therapy. We determined crystal structures for human coronavirus (strain 229E) M-pro and for an inhibitor complex of porcine coronavirus [ transmissible gastroenteritis virus ( TGEV)] Mpro, and we constructed a homology model for SARS coronavirus (SARS-CoV) M-pro. The structures reveal a remarkable degree of conservation of the substrate-binding sites, which is further supported by recombinant SARS-CoV M-pro-mediated cleavage of a TGEV Mpro substrate. Molecular modeling suggests that available rhinovirus 3C(pro) inhibitors may be modified to make them useful for treating SARS.
引用
收藏
页码:1763 / 1767
页数:5
相关论文
共 18 条
[1]   Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra α-helical domain [J].
Anand, K ;
Palm, GJ ;
Mesters, JR ;
Siddell, SG ;
Ziebuhr, J ;
Hilgenfeld, R .
EMBO JOURNAL, 2002, 21 (13) :3213-3224
[2]   Identification of a novel coronavirus in patients with severe acute respiratory syndrome [J].
Drosten, C ;
Günther, S ;
Preiser, W ;
van der Werf, S ;
Brodt, HR ;
Becker, S ;
Rabenau, H ;
Panning, M ;
Kolesnikova, L ;
Fouchier, RAM ;
Berger, A ;
Burguière, AM ;
Cinatl, J ;
Eickmann, M ;
Escriou, N ;
Grywna, K ;
Kramme, S ;
Manuguerra, JC ;
Müller, S ;
Rickerts, V ;
Stürmer, M ;
Vieth, S ;
Klenk, HD ;
Osterhaus, ADME ;
Schmitz, H ;
Doerr, HW .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (20) :1967-1976
[3]   Conservation of substrate specificities among coronavirus main proteases [J].
Hegyi, A ;
Ziebuhr, J .
JOURNAL OF GENERAL VIROLOGY, 2002, 83 :595-599
[4]   Mutational analysis of the active centre of coronavirus 3C-like proteases [J].
Hegyi, A ;
Friebe, A ;
Gorbalenya, AE ;
Ziebuhr, J .
JOURNAL OF GENERAL VIROLOGY, 2002, 83 :581-593
[5]   NUCLEOTIDE-SEQUENCE OF THE HUMAN CORONAVIRUS 229E RNA-POLYMERASE LOCUS [J].
HEROLD, J ;
RAABE, T ;
SCHELLEPRINZ, B ;
SIDDELL, SG .
VIROLOGY, 1993, 195 (02) :680-691
[6]  
KRAUSSLICH HG, 1988, ANNU REV BIOCHEM, V57, P701, DOI 10.1146/annurev.bi.57.070188.003413
[7]   A novel coronavirus associated with severe acute respiratory syndrome [J].
Ksiazek, TG ;
Erdman, D ;
Goldsmith, CS ;
Zaki, SR ;
Peret, T ;
Emery, S ;
Tong, SX ;
Urbani, C ;
Comer, JA ;
Lim, W ;
Rollin, PE ;
Dowell, SF ;
Ling, AE ;
Humphrey, CD ;
Shieh, WJ ;
Guarner, J ;
Paddock, CD ;
Rota, P ;
Fields, B ;
DeRisi, J ;
Yang, JY ;
Cox, N ;
Hughes, JM ;
LeDuc, JW ;
Bellini, WJ ;
Anderson, LJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (20) :1953-1966
[8]   A major outbreak of severe acute respiratory syndrome in Hong Kong [J].
Lee, N ;
Hui, D ;
Wu, A ;
Chan, P ;
Cameron, P ;
Joynt, GM ;
Ahuja, A ;
Yung, MY ;
Leung, CB ;
To, KF ;
Lui, SF ;
Szeto, CC ;
Chung, S ;
Sung, JJY .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (20) :1986-1994
[9]  
MARRA M, 2003, SCIENCE, V30, P1399, DOI DOI 10.1126/SC2ENCE.1085953
[10]   Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes [J].
Matthews, DA ;
Dragovich, PS ;
Webber, SE ;
Fuhrman, SA ;
Patick, AK ;
Zalman, LS ;
Hendrickson, TF ;
Love, RA ;
Prins, TJ ;
Marakovits, JT ;
Zhou, R ;
Tikhe, J ;
Ford, CE ;
Meador, JW ;
Ferre, RA ;
Brown, EL ;
Binford, SL ;
Brothers, MA ;
DeLisle, DM ;
Worland, ST .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (20) :11000-11007